{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:48:52Z","timestamp":1784033332742,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>N<jats:sup>6<\/jats:sup>-(R)-Phenylisopropyladenosine (R-PIA), an agonist at A<jats:sub>1<\/jats:sub>-adenosine receptors, alone exerts negative inotropic effects (NIE) in the human atrium. This NIE is augmented in the presence of cAMP-increasing agonists like phosphodiesterase inhibitors (cilostamide, rolipram) or a direct activator of adenylyl cyclase (forskolin). Cantharidin inhibits protein phosphatases 1 and 2A (PP1, PP2A). We hypothesized that cantharidin would attenuate this NIE of R-PIA in the presence of cilostamide or forskolin. During open heart surgery (patients were suffering from severe coronary heart disease), isolated human atrial preparations (HAP) were obtained. These HAP were mounted in organ baths and electrically stimulated (1 Hz). For comparison, we studied isolated electrically stimulated (1 Hz) left atrial preparations (LA) from wild type mice. We noted that R-PIA exerted negative inotropic effects in LA and HAP in the presence of cilostamide or rolipram and forskolin that were attenuated by cantharidin. We hypothesize that R-PIA in the presence of phosphodiesterase inhibitors or forskolin stimulates PP in the human atrium. Hence, R-PIA acts, at least in part, by stimulating PP in HAP.<\/jats:p>","DOI":"10.1007\/s00210-025-03854-0","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:25:07Z","timestamp":1738733107000},"page":"9125-9138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibition of protein phosphatases attenuates A1-adenosine receptor-stimulation induced negative inotropic effects of cAMP-increasing agents in the isolated human atrium"],"prefix":"10.1007","volume":"398","author":[{"given":"Rebecca","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Gergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"7","key":"3854_CR1","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1016\/S0021-9258(19)84930-X","volume":"264","author":"Z Ahmad","year":"1989","unstructured":"Ahmad Z, Green FJ, Subuhi HS, Watanabe AM (1989) Autonomic regulation of type 1 protein phosphatase in cardiac muscle. J Biol Chem 264(7):3859\u20133863","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"3854_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF00227896","volume":"157","author":"S Bartel","year":"1996","unstructured":"Bartel S, Stein B, Eschenhagen T, Mende U, Neumann J, Schmitz W, Krause EG, Karczewski P, Scholz H (1996) Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts. Mol Cell Biochem. 157(1\u20132):171\u20139. https:\/\/doi.org\/10.1007\/BF00227896","journal-title":"Mol Cell Biochem."},{"key":"3854_CR3","doi-asserted-by":"publisher","unstructured":"Baumann G, Felix SB, Schrader J, Heidecke CD, Riess G, Erhardt WD, Ludwig L, Loher U, Sebening F, Bl\u00f6mer H (1981) Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardium. Res Exp Med (Berl) 179(1):81\u201398. https:\/\/doi.org\/10.1007\/BF01852128","DOI":"10.1007\/BF01852128"},{"issue":"Pt 3","key":"3854_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1469-7793.2001.00779.x","volume":"537","author":"AE Belevych","year":"2001","unstructured":"Belevych AE, Nulton-Persson A, Sims C (2001) Harvey RD Role of tyrosine kinase activity in alpha-adrenergic inhibition of the beta-adrenergically regulated L-type Ca(2+) current in guinea-pig ventricular myocytes. J Physiol 537(Pt 3):779\u2013792. https:\/\/doi.org\/10.1111\/j.1469-7793.2001.00779.x","journal-title":"J Physiol"},{"issue":"3","key":"3854_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0014-2999(85)90170-0","volume":"116","author":"M B\u00f6hm","year":"1985","unstructured":"B\u00f6hm M, Meyer W, M\u00fcgge A, Schmitz W, Scholz H (1985a) Functional evidence for the existence of adenosine receptors in the human heart. Eur J Pharmacol 116(3):323\u2013326. https:\/\/doi.org\/10.1016\/0014-2999(85)90170-0","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"3854_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/BF00634229","volume":"331","author":"M B\u00f6hm","year":"1985","unstructured":"B\u00f6hm M, Br\u00fcckner R, Meyer W, Nose M, Schmitz W, Scholz H, Starbatty J (1985b) Evidence for adenosine receptor-mediated isoprenaline-antagonistic effects of the adenosine analogs PIA and NECA on force of contraction in guinea-pig atrial and ventricular cardiac preparations. Naunyn Schmiedebergs Arch Pharmacol 331(2\u20133):131\u2013139. https:\/\/doi.org\/10.1007\/BF00634229","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"3854_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1476-5381.1988.tb11456.x","volume":"93","author":"M B\u00f6hm","year":"1988","unstructured":"B\u00f6hm M, Br\u00fcckner R, Neumann J, Nose M, Schmitz W, Scholz H (1988) Adenosine inhibits the positive inotropic effect of 3-isobutyl-1-methylxanthine in papillary muscles without effect on cyclic AMP or cyclic GMP. Br J Pharmacol 93(4):729\u2013738. https:\/\/doi.org\/10.1111\/j.1476-5381.1988.tb11456.x","journal-title":"Br J Pharmacol"},{"issue":"5","key":"3854_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1161\/01.res.65.5.1201","volume":"65","author":"M B\u00f6hm","year":"1989","unstructured":"B\u00f6hm M, Pieske B, Ungerer M, Erdmann E (1989) Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res 65(5):1201\u20131211. https:\/\/doi.org\/10.1161\/01.res.65.5.1201","journal-title":"Circ Res"},{"key":"3854_CR9","doi-asserted-by":"crossref","unstructured":"B\u00f6hm M, Br\u00fcckner R, Hackbarth I, Haubitz B, Linhart R, Meyer W, Schmidt B, Schmitz W, Scholz H (1984) Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. J Pharmacol Exp Ther 230(2):483\u201392","DOI":"10.1016\/S0022-3565(25)21575-0"},{"key":"3854_CR10","doi-asserted-by":"publisher","unstructured":"B\u00f6hm M, Br\u00fcckner R, Neumann J, Schmitz W, Scholz H, Starbatty J (1986) Role of guanine nucleotide-binding protein in the regulation by adenosine of cardiac potassium conductance and force of contraction. Evaluation with pertussis toxin. Naunyn Schmiedebergs Arch Pharmacol 332(4):403\u20135. https:\/\/doi.org\/10.1007\/BF00500095","DOI":"10.1007\/BF00500095"},{"key":"3854_CR11","first-page":"H786","volume":"280","author":"P Boknik","year":"2001","unstructured":"Boknik P, Khorchidi S, Bodor GS, Huke S, Knapp J, Linck B, L\u00fcss H, M\u00fcller FU, Schmitz W, Neumann J (2001) Role of protein phosphatases in the regulation of cardiac inotropy and relaxation. Am J Physiol 280:H786-794","journal-title":"Am J Physiol"},{"key":"3854_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1111\/j.1476-5381.2009.00441.x","volume":"158","author":"P Boknik","year":"2009","unstructured":"Boknik P, Grote-Wessels S, Barteska G, Jiang M, M\u00fcller FU, Schmitz W, Neumann J, Birnbaumer L (2009) Genetic disruption of Gi\u03b12 and Go\u03b1 does not abolish inotropic and chronotropic effects of M-cholinoceptor stimulation in atria. Br J Pharmacol 158:1557\u20131564","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3854_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1172\/JCI111404","volume":"74","author":"MR Bristow","year":"1984","unstructured":"Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W (1984) Pharmacology and inotropic potential of forskolin in the human heart. J Clin Invest 74(1):212\u2013223. https:\/\/doi.org\/10.1172\/JCI111404","journal-title":"J Clin Invest"},{"issue":"1","key":"3854_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","volume":"120","author":"G Burnstock","year":"2017","unstructured":"Burnstock G (2017) Purinergic signaling in the cardiovascular system. Circ Res 120(1):207\u2013228. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309726","journal-title":"Circ Res"},{"issue":"3","key":"3854_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00210-006-0119-5","volume":"374","author":"T Christ","year":"2006","unstructured":"Christ T, Engel A, Ravens U, Kaumann AJ (2006) Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through beta(2)-adrenoceptors than the effects of (-)-noradrenaline through beta (1)-adrenoceptors in human atrial myocardium. Naunyn Schmiedebergs Arch Pharmacol 374(3):249\u2013253. https:\/\/doi.org\/10.1007\/s00210-006-0119-5","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3854_CR16","doi-asserted-by":"publisher","unstructured":"Christ T, Rozmaritsa N, Engel A, Berk E, Knaut M, Metzner K, Canteras M, Ravens U, Kaumann A (2014) Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proc Natl Acad Sci U S A 111(30):11193\u20138. https:\/\/doi.org\/10.1073\/pnas.1324132111. Erratum in: Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):14003","DOI":"10.1073\/pnas.1324132111"},{"issue":"2","key":"3854_CR17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1152\/physrev.00015.2023","volume":"104","author":"Q Fu","year":"2024","unstructured":"Fu Q, Wang Y, Yan C, Xiang YK (2024) Phosphodiesterase in heart and vessels: from physiology to diseases. Physiol Rev 104(2):765\u2013834","journal-title":"Physiol Rev"},{"issue":"6","key":"3854_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0022-2828(91)90984-t","volume":"23","author":"EE George","year":"1991","unstructured":"George EE, Romano FD, Dobson JG Jr (1991) Adenosine and acetylcholine reduce isoproterenol-induced protein phosphorylation of rat myocytes. J Mol Cell Cardiol 23(6):749\u2013764. https:\/\/doi.org\/10.1016\/0022-2828(91)90984-t","journal-title":"J Mol Cell Cardiol"},{"key":"3854_CR19","doi-asserted-by":"publisher","unstructured":"Gergs U, Wackerhagen S, Fuhrmann T, Sch\u00e4fer I, Neumann J (2024) Further investigations on the influence of protein phosphatases on the signaling of muscarinic receptors in the atria of mouse hearts. Naunyn-Schmiedeberg\u00b4s Arch Pharmacol https:\/\/doi.org\/10.1007\/s00210-024-02973-4","DOI":"10.1007\/s00210-024-02973-4"},{"key":"3854_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1023\/A:1006899931151","volume":"187","author":"RC Gupta","year":"1998","unstructured":"Gupta RC, Neumann J, Watanabe AM, Sabbah HN (1998) Muscarinic-cholinoceptor mediated attenuation of protein phosphorylation in ventricular cardiomyocytes: evidence against a cAMP-dependent effect. Mol Cell Biochem 187:155\u2013161","journal-title":"Mol Cell Biochem"},{"key":"3854_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1152\/physrev.2000.80.1.173","volume":"80","author":"S Herzig","year":"2000","unstructured":"Herzig S, Neumann J (2000) Effects of serine\/threonine phosphatases on ion channels in excitable membranes. Physiol Rev 80:173\u2013210","journal-title":"Physiol Rev"},{"key":"3854_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/BF00704158","volume":"429","author":"S Herzig","year":"1995","unstructured":"Herzig S, Meier A, Pfeiffer M, Neumann J (1995) Stimulation of protein phosphatases as a mechanism of the muscarinic receptor-mediated inhibition of cardiac L-type calcium channels. Pfl\u00fcgers Arch (Eur J Physiol) 429:531\u2013538","journal-title":"Pfl\u00fcgers Arch (Eur J Physiol)"},{"key":"3854_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pbiomolbio.2021.05.006","volume":"166","author":"M Hoekstra","year":"2021","unstructured":"Hoekstra M, van Ginneken ACG, Wilders R, Verkerk AO (2021) HCN4 current during human sinoatrial node-like action potentials. Prog Biophys Mol Biol 166:105\u2013118. https:\/\/doi.org\/10.1016\/j.pbiomolbio.2021.05.006","journal-title":"Prog Biophys Mol Biol"},{"key":"3854_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0306-3623(98)00053-6","volume":"31","author":"J Knapp","year":"1998","unstructured":"Knapp J, Boknik P, Huke S, Gombosova I, Linck B, L\u00fcss H, M\u00fcller FU, M\u00fcller T, Nacke P, Schmitz W, Vahlensieck U, Neumann J (1998) Contractility and inhibition of protein phosphatases by cantharidin. Gen Pharmacol 31:729\u2013733","journal-title":"Gen Pharmacol"},{"issue":"5","key":"3854_CR25","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/01.res.29.5.437","volume":"29","author":"MN Levy","year":"1971","unstructured":"Levy MN (1971) Sympathetic-parasympathetic interactions in the heart. Circ Res 29(5):437\u2013445. https:\/\/doi.org\/10.1161\/01.res.29.5.437","journal-title":"Circ Res"},{"issue":"24","key":"3854_CR26","doi-asserted-by":"publisher","first-page":"13122","DOI":"10.1016\/S0021-9258(17)38847-6","volume":"260","author":"JP Lindemann","year":"1985","unstructured":"Lindemann JP, Watanabe AM (1985) Muscarinic cholinergic inhibition of beta-adrenergic stimulation of phospholamban phosphorylation and Ca2+ transport in guinea pig ventricles. J Biol Chem 260(24):13122\u201313129","journal-title":"J Biol Chem"},{"key":"3854_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-642-17969-3_10","volume":"204","author":"MA Movsesian","year":"2011","unstructured":"Movsesian MA, Kukreja RC (2011) Phosphodiesterase inhibition in heart failure. Handb Exp Pharmacol 204:237\u2013249. https:\/\/doi.org\/10.1007\/978-3-642-17969-3_10","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"3854_CR28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2362.1988.tb01274.x","volume":"18","author":"M N\u00e4bauer","year":"1988","unstructured":"N\u00e4bauer M, B\u00f6hm M, Brown L, Diet F, Eichhorn M, Kemkes B, Pieske B, Erdmann E (1988) Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts. Eur J Clin Invest 18(6):600\u2013606. https:\/\/doi.org\/10.1111\/j.1365-2362.1988.tb01274.x","journal-title":"Eur J Clin Invest"},{"key":"3854_CR29","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/01.RES.69.6.1450","volume":"69","author":"J Neumann","year":"1991","unstructured":"Neumann J, Gupta RC, Schmitz W, Scholz H, Nairn AC, Watanabe AM (1991) Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ Res 69:1450\u20131457","journal-title":"Circ Res"},{"key":"3854_CR30","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0022-3565(25)38882-8","volume":"269","author":"J Neumann","year":"1994","unstructured":"Neumann J, Boknik P, Bodor GS, Jones LR, Schmitz W, Scholz H (1994) Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin. J Pharmacol Exp Ther 269:1310\u20131318","journal-title":"J Pharmacol Exp Ther"},{"key":"3854_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0014-2999(95)00569-2","volume":"294","author":"J Neumann","year":"1995","unstructured":"Neumann J, Kaspareit G, Kirchhefer U, Scholz H (1995a) Sodium fluoride attenuates the negative inotropic effects of muscarinic M2 and adenosine receptor agonists. Eur J Pharmacol 294:451\u2013457","journal-title":"Eur J Pharmacol"},{"key":"3854_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0022-3565(25)10676-9","volume":"274","author":"J Neumann","year":"1995","unstructured":"Neumann J, Herzig S, Boknik P, Apel M, Kaspareit G, Schmitz W, Scholz H, Zimmermann N (1995b) On the cardiac contractile, biochemical and electrophysiological effects of cantharidin, a phosphatase inhibitor. J Pharmacol Exp Ther 274:530\u2013539","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"3854_CR33","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S0022-3565(25)13111-X","volume":"277","author":"J Neumann","year":"1996","unstructured":"Neumann J, Eschenhagen T, Grupp IL, Haverich A, Herzig JW, Hirt S, Kalm\u00e1r P, Schmitz W, Scholz H, Stein B, Wenzlaff H, Zimmermann N (1996) Positive inotropic effects of the calcium sensitizer CGP 48506 in failing human myocardium. J Pharmacol Exp Ther 277(3):1579\u20131585","journal-title":"J Pharmacol Exp Ther"},{"key":"3854_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00005344-199901000-00024","volume":"33","author":"J Neumann","year":"1999","unstructured":"Neumann J, Bartel S, Eschenhagen T, Haverich H, Hirt S, Kalm\u00e1r P, Karczewski P, Krause EG, Schmitz W, Scholz H, Stein B, Thoenes M (1999a) Dissociation of the effects of forskolin and dibutyryl cAMP on force of contraction and phospholamban phosphorylation in human heart failure. J Cardiovasc Pharmacol 33:157\u2013162","journal-title":"J Cardiovasc Pharmacol"},{"key":"3854_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/sj.bjp.0702963","volume":"128","author":"J Neumann","year":"1999","unstructured":"Neumann J, Vahlensieck U, Boknik P, Linck B, L\u00fcss H, M\u00fcller FU, Matherne GP, Schmitz W (1999b) Functional studies in atrium overexpressing A1-adenosine receptors. Br J Pharmacol 128:1623\u20131629","journal-title":"Br J Pharmacol"},{"key":"3854_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/sj.bjp.0705012","volume":"138","author":"J Neumann","year":"2003","unstructured":"Neumann J, Boknik P, Matherne GP, Lankford A, Schmitz W (2003) Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A1\u2013adenosine receptors. Br J Pharmacol 138:209\u2013217","journal-title":"Br J Pharmacol"},{"key":"3854_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00210-019-01653-y","volume":"392","author":"J Neumann","year":"2019","unstructured":"Neumann J, K\u00e4ufler B, Gergs U (2019) Which phosphodiesterase can decrease cardiac effects of 5-HT4 receptor activation in transgenic mice? Naunyn Schmiedebergs Arch Pharmacol 392:991\u20131004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3854_CR38","doi-asserted-by":"crossref","unstructured":"Neumann J, Boknik P, Kirchhefer U, Gergs U (2021a) The role of PP5 and PP2C in cardiac health and disease. Cell Signal 2021;85:110035","DOI":"10.1016\/j.cellsig.2021.110035"},{"issue":"5","key":"3854_CR39","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/FJC.0000000000001237","volume":"79","author":"J Petersen","year":"2022","unstructured":"Petersen J, Castro L, Bengaard AKP, Pecha S, Ismaili D, Schulz C, Sahni J, Steenpass A, Meier C, Reichenspurner H, Jespersen T, Eschenhagen T, Christ T (2022) Muscarinic receptor activation reduces force and arrhythmias in human atria independent of IK. Ach J Cardiovasc Pharmacol 79(5):678\u2013686. https:\/\/doi.org\/10.1097\/FJC.0000000000001237","journal-title":"Ach J Cardiovasc Pharmacol"},{"key":"3854_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00210-022-02348-7","volume":"396","author":"LM RayoAbella","year":"2023","unstructured":"RayoAbella LM, Hoffmann R, Neumann J, Hofmann B, Gergs U (2023a) Levosimendan increases the phosphorylation state of phospholamban in the isolated human atrium. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 396:669\u2013682. https:\/\/doi.org\/10.1007\/s00210-022-02348-7","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"3854_CR41","doi-asserted-by":"publisher","unstructured":"Rayo Abella LM, Grundig P, Bernhardt MN, Hofmann B, Neumann J, Gergs U (2023b) OR-1896 increases the force of contraction in the isolated human atrium. Naunyn-Schmiedeberg\u00b4s Arch Pharmacol 396(12):3823\u20133833. https:\/\/doi.org\/10.1007\/s00210-023-02592-5","DOI":"10.1007\/s00210-023-02592-5"},{"key":"3854_CR42","doi-asserted-by":"publisher","unstructured":"Schwarz R, Hofmann B, Gergs U, Neumann J (2023a) Cantharidin increases the force of contraction and protein phosphorylation in the isolated human atrium. Naunyn- Schmiedeberg\u00b4s Arch Pharmacol 396(10):2613\u20132625; https:\/\/doi.org\/10.1007\/s00210-023-02483-9","DOI":"10.1007\/s00210-023-02483-9"},{"key":"3854_CR43","doi-asserted-by":"publisher","unstructured":"Schwarz R, Hofmann B, Gergs U, Neumann J (2023b) Cantharidin and sodium fluoride attenuate the negative inotropic effects of carbachol in the isolated human atrium. Naunyn-Schmiedeberg\u00b4s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02747-4","DOI":"10.1007\/s00210-023-02747-4"},{"key":"3854_CR44","doi-asserted-by":"publisher","unstructured":"Schwarz R, Hofmann B, Gergs U, Neumann J (2024) Cantharidin and sodium fluoride attenuate the negative inotropic effects of the adenosine A1 receptor agonist N6-(R)-phenylisopropyladenosine in isolated human atria. Naunyn-Schmiedeberg\u00b4s Arch Pharmacol.https:\/\/doi.org\/10.1007\/s00210-024-03402-2 \u00a0","DOI":"10.1007\/s00210-024-03402-2"},{"issue":"4","key":"3854_CR45","first-page":"201","volume":"7","author":"KB Seamon","year":"1981","unstructured":"Seamon KB, Daly JW (1981) Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 7(4):201\u2013224","journal-title":"J Cyclic Nucleotide Res"},{"issue":"2","key":"3854_CR46","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1476-5381.1992.tb14276.x","volume":"105","author":"M Steinfath","year":"1992","unstructured":"Steinfath M, Danielsen W, von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H et al (1992) Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Br J Pharmacol 105(2):463\u2013469. https:\/\/doi.org\/10.1111\/j.1476-5381.1992.tb14276.x","journal-title":"Br J Pharmacol"},{"issue":"1","key":"3854_CR47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/hh0102.103222","volume":"90","author":"JW Wegener","year":"2002","unstructured":"Wegener JW, Nawrath H, Wolfsgruber W, K\u00fchbandner S, Werner C, Hofmann F, Feil R (2002) cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ Res 90(1):18\u201320. https:\/\/doi.org\/10.1161\/hh0102.103222","journal-title":"Circ Res"},{"issue":"5 Pt 2","key":"3854_CR48","doi-asserted-by":"publisher","first-page":"H769","DOI":"10.1152\/ajpheart.1986.250.5.H769","volume":"250","author":"GA West","year":"1986","unstructured":"West GA, Isenberg G, Belardinelli L (1986) Antagonism of forskolin effects by adenosine in isolated hearts and ventricular myocytes. Am J Physiol 250(5 Pt 2):H769\u2013H777. https:\/\/doi.org\/10.1152\/ajpheart.1986.250.5.H769","journal-title":"Am J Physiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03854-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03854-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03854-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:35:43Z","timestamp":1757133343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03854-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3854"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03854-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The investigation conformed to the Guide for the Care and Use of Laboratory Animals as published by the National Research Council (2011). The animals were handled and maintained according to the approved protocols of the Animal Welfare Committee of the University of Halle-Wittenberg, Halle, Germany. Humans: This study complies with the Declaration of Helsinki and has been approved by the local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors declare that they have seen and approved the submitted version of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}